| Clinical Trial of CD5-targeted CAR-NK Therapy for Relapse/Refractory T-Cell Hematologic Malignancies (NCT06909474) | Chongqing Precision Biotech Co., Ltd | 2025-03-27 |
| A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases (NCT06647069) | Sanofi | 2025-03-27 |
| To Compare the Pharmacokinetics, Safety, and Immunogenicity of Subcutaneous CT-P6 and Herceptin in Healthy Male Subjects (Trastuzumab) (NCT06687928) | Celltrion | 2025-03-26 |
| A Clinical Study to Explore the Safety, Tolerability, and Efficacy of Recombinant Human nsIL12 Oncolytic Adenovirus Injection (BioTTT001) Combined With Neoadjuvant Treatment for Locally Advanced Breast Cancer (NCT07150767) | Beijing Bio-Targeting Therapeutics Technology Co., Ltd | 2025-03-26 |
| A Study to Test Whether Survodutide Improves How the Body Uses Energy and Breaks Down Fat in People With Obesity (NCT06745284) | Boehringer Ingelheim | 2025-03-26 |
| EBV-AST Cell Therapy for EBV-Related Diseases After Stem Cell Transplantation (NCT07438067) | Daihong Liu | 2025-03-26 |
| Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors (NCT06635785) | OncoC4, Inc. | 2025-03-26 |
| Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers (NCT06889350) | Handok Inc. | 2025-03-26 |
| A Study to Assess the Relative Bioavailability of Oral Tavapadon in Healthy Adult Participants (NCT06895356) | AbbVie | 2025-03-26 |
| Safety, Tolerability, and PK/PD of Telpegfilgrastim in Premenopausal Non-pregnant Females (NCT06893796) | Xiamen Amoytop Biotech Co., Ltd. | 2025-03-26 |
| Bacteriophage Therapy for Morganella Morganii Prosthetic Joint Infection (NCT06814756) | University of Calgary | 2025-03-26 |
| A Study of Bimagrumab Alone (LY3985863) and Bimagrumab With Tirzepatide (LY900042) in Healthy Participants (NCT06890611) | Eli Lilly and Company | 2025-03-25 |
| Post-CA Neuroprotection With Magnesium (NCT06455514) | NYU Langone Health | 2025-03-25 |
| Study of CM313(SC) Injection in Subjects With Platelet Transfusion Refractoriness (NCT06792019) | Keymed Biosciences Co.Ltd | 2025-03-25 |
| A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002) (NCT06818643) | Merck Sharp & Dohme LLC | 2025-03-25 |
| A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors (NCT06764771) | Bristol-Myers Squibb | 2025-03-25 |
| A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental Vitiligo (NCT06905873) | Forte Biosciences, Inc. | 2025-03-25 |
| A Study to Assess How Food Affects the Movement of Oral ABBV-101 Through the Body of Healthy Adult Participants (NCT06887010) | AbbVie | 2025-03-25 |
| Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib (NCT06899061) | AstraZeneca | 2025-03-25 |
| A Phase 1 Study in Healthy Volunteers to Evaluate the Relative Bioavailability of ALG-055009 Formulations (NCT06959888) | Aligos Therapeutics | 2025-03-25 |
| A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors (NCT06880549) | ModernaTX, Inc. | 2025-03-25 |
| Platform Trial Evaluating Treatment of Neoadjuvant Trastuzumab-deruxtecan Containing Combination Therapies for HER2+, Resectable Esophagogastric Adenocarcinoma (NCT06731803) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2025-03-25 |
| This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile. (NCT06756451) | Nanjing RegeneCore Biotech Co., Ltd. | 2025-03-25 |
| A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors (NCT07029399) | NiKang Therapeutics, Inc. | 2025-03-25 |
| Evaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer (NCT07056777) | Zhejiang Doer Biologics Co., Ltd. | 2025-03-25 |
| PK,PD and DDI of Epaminurad and C2406 in Healthy Volunteers (NCT06665425) | JW Pharmaceutical | 2025-03-24 |
| Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss (NCT06810544) | Tango Therapeutics, Inc. | 2025-03-24 |
| Anti-CEA CAR-T for Advanced CEA-Positive Lung Carcinoma (NCT06903117) | Chongqing Precision Biotech Co., Ltd | 2025-03-24 |
| NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma (NCT06889766) | Centre Hospitalier Universitaire Vaudois | 2025-03-24 |
| A Study of BGM0504 in Overweight or Obese Participants (NCT06920056) | BrightGene Bio-Medical Technology Co., Ltd. | 2025-03-24 |
| A Study of TAK-881 and HyQvia in Healthy Adults (NCT06895967) | Takeda | 2025-03-24 |
| A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata (NCT06826196) | Aldena Therapeutics | 2025-03-24 |
| Studying TAK-243 in Patients With Advanced Cancer (NCT06223542) | National Cancer Institute (NCI) | 2025-03-24 |
| Evaluation of the Safety, Tolerability and Pharmacokinetics of AH-001 Following Topical Single and Multiple Ascending Dose Administration (NCT06927960) | AnHorn Medicines Co. Ltd. | 2025-03-24 |
| A Study to Evaluate the Mass Balance, Metabolism, Elimination, and Drug Levels of [14C]-BMS-986504 (MRTX1719) in Participants With Advanced Solid Tumors With Homozygous Methylthioadenosine Phosphorylase Deletion (NCT06672523) | Bristol-Myers Squibb | 2025-03-24 |
| LIV001 in Patients with Mild-to-Moderate Active Ulcerative Colitis (UC) (NCT06749795) | Liveome Inc. | 2025-03-24 |
| Use of Intranasal Midazolam to Reduce Stress and Procedural Pain in Premature Infants During Routine ROP Examination. (NCT06889376) | Polish Mother Memorial Hospital Research Institute | 2025-03-24 |
| A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors (NCT06827613) | Marengo Therapeutics, Inc. | 2025-03-24 |
| REGEND001 Autologous Basal Layer Stem Cell Transplantation for Chronic Obstructive Pulmonary Disease (COPD): A Translational Application Study (NCT06946953) | Ruijin Hospital | 2025-03-23 |
| Propolis Lozenges Extract and Their Effect on Salivary Biomarkers and on Oral Health Condition in (19_24) Years Old (NCT06888453) | Al-Mustansiriyah University | 2025-03-23 |
| ENX-205 SAD/PET Study in Healthy Adults (NCT07253246) | Engrail Therapeutics INC | 2025-03-23 |
| PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors (NCT06721689) | Theodore Laetsch | 2025-03-23 |
| An Open-label Pharmacokinetic Study of TS-172 in Patients on Hemodialysis (NCT06849778) | Taisho Pharmaceutical Co., Ltd. | 2025-03-22 |
| A Phase 1b/2 Clinical Trial Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AUR103 Calcium in Patients With HER2-positive Advanced Gastric/Gastroesophageal Junction Adenocarcinoma (NCT07040059) | Aurigene Discovery Technologies Limited | 2025-03-22 |
| First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer (NCT06799065) | Accent Therapeutics | 2025-03-21 |
| QL1706 Combined With SOX Used in Theperioperative Treatment (NCT06766305) | Xiangdong Cheng | 2025-03-21 |
| A Study of ATTR-01 in Participants With Select Epithelial Solid Tumours (NCT06977737) | Accession Therapeutics Limited | 2025-03-21 |
| Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adults (NCT06843317) | Clover Biopharmaceuticals USA, LLC | 2025-03-21 |
| A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors (NCT06914128) | Bayer | 2025-03-21 |
| The Study Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151' (NCT06902818) | Addpharma Inc. | 2025-03-21 |
| Gene Editing For Sickle Cell Disease (NCT06506461) | St. Jude Children's Research Hospital | 2025-03-21 |
| A Study to Evaluate How the Body Processes 14C-VX-993 After a Single Oral Dose (NCT06886269) | Vertex Pharmaceuticals Incorporated | 2025-03-21 |
| Efficacy and Safety of the ACC017-Based Antiretroviral Regimen in Treatment-Experienced Adults With HIV-1 Harboring Non-Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations (NCT07711210) | Jiangsu Aidea Pharmaceutical Group Co., Ltd. | 2025-03-21 |
| A Study to Learn if the Study Medicine Called Carbamazepine Changes How the Body Processes PF-07220060 (NCT06897683) | Pfizer | 2025-03-21 |
| Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT (NCT06839456) | Children's Hospital of Philadelphia | 2025-03-21 |
| A Study of JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms (NCT06651229) | Janssen Research & Development, LLC | 2025-03-21 |
| Assess the Safety, Tolerability, and Pharmacokinetics of HL-1186 in Healthy Participants (NCT06912295) | Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. | 2025-03-21 |
| SBRT-LDRT-Cadonilimab for Advanced Gastric, Colorectal and Ovarian Cancers With Peritoneal Metastases (NCT06940921) | Zhang Tao | 2025-03-20 |
| JAB-21822 Combined With Chemotherapy and Bevacizumab in Second-line KRAS G12C CRC (NCT06838338) | Jian Li | 2025-03-20 |
| Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19) (NCT05387278) | Vitti Labs, LLC | 2025-03-20 |
| A Study of Oral YUQ-A1007 in Healthy Volunteers (NCT06835296) | Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. | 2025-03-20 |
| A Phase 1 Study of BHV-1530 in Advanced Solid Tumors (NCT06874335) | Biohaven Therapeutics Ltd. | 2025-03-20 |
| BCMA-CD19 cCAR-T for the Treatment of Refractory Inflammatory Myopathy (NCT07715136) | iCell Gene Therapeutics | 2025-03-20 |
| A Study of LY4064809 [14C]-STX-478 in Healthy Male Participants (NCT06901336) | Scorpion Therapeutics, a wholly owned subsidiary of Eli Lilly and Company | 2025-03-20 |
| A Study to Investigate Safety, Tolerability and Pharmacokinetics of REM0045392 Compared With Placebo in Healthy Participants. (NCT07016464) | reMYND | 2025-03-20 |
| Chronic Lung Allograft Dysfunction MRI Study (NCT06406777) | Sean Fain | 2025-03-20 |
| Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease (NCT06529822) | Washington University School of Medicine | 2025-03-20 |
| Clinical Trial of SYS6010±SYH2051 Versus Chemotherapy in Advanced Breast Cancer and Other Solid Tumors (NCT06775236) | CSPC Megalith Biopharmaceutical Co.,Ltd. | 2025-03-20 |
| Validation Study of an Assistive Pulse Data Collection Device (NCT06974227) | The Hong Kong Polytechnic University | 2025-03-20 |
| Trial of Cell Based Therapy for DMD (NCT06692426) | Masonic Cancer Center, University of Minnesota | 2025-03-20 |
| Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer (NCT06225011) | Jonsson Comprehensive Cancer Center | 2025-03-20 |
| Impact of Tactile Kinesthetic Stimulation and Soft Tissue Manipulation on Cortisol in Preterm (NCT06845137) | faizan kashoo, PT | 2025-03-20 |
| PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder (NCT06795581) | National Institute of Mental Health (NIMH) | 2025-03-20 |
| A Study of MK-8527 in Healthy Adult Participants (MK-8527-013) (NCT06826989) | Merck Sharp & Dohme LLC | 2025-03-19 |
| A Study of the Safety, Tolerability, and Pharmacokinetics of NYR-BI03 in Healthy Participants (NCT06894862) | Nyrada Pty Ltd | 2025-03-19 |
| A Study of Intravenous VRT106 for Locally Advanced or Metastatic Solid Tumors (NCT06826313) | Guangzhou Virotech Pharmaceutical Co., Ltd. | 2025-03-19 |
| Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL) (NCT06644183) | Jennifer R. Brown, MD, PhD | 2025-03-19 |
| A Single-dose Study to Evaluate the Safety, Tolerability, Drug Levels, and Relative Biological Availability of Alternate Formulations of BMS-986460 in Healthy Adult Male Participants (NCT06877702) | Bristol-Myers Squibb | 2025-03-19 |
| Pharmacokinetics Study of TNO155 in Participants With Mild, Moderate, or Severe Renal Impairment Compared to Matched Healthy Participants (NCT05541159) | Novartis Pharmaceuticals | 2025-03-19 |
| A Study to Learn if Study Medicines Called Cyclosporine and Clarithromycin Affect How the Body Processes the Other Study Medicine Called PF-07328948 in Healthy Adults (NCT06837259) | Pfizer | 2025-03-19 |
| A Phase 1 Study of Neoadjuvant Abemaciclib in Combination With Radiation Therapy for Liposarcomas (NCT06025747) | University of Washington | 2025-03-19 |
| A Study in Healthy Men to Test Whether Food Influences the Amount of BI 3731579 in the Blood (NCT06861829) | Boehringer Ingelheim | 2025-03-19 |
| A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainfluenza Vaccines in Adults 18 to 49 Years of Age. (NCT06850051) | Sanofi | 2025-03-19 |
| PIN in Combination With Anti-PD1 in Previously Treated Solid Tumor (NCT06883149) | Chinese PLA General Hospital | 2025-03-19 |
| Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma (NCT06830031) | Shanghai Exuma Biotechnology Ltd. | 2025-03-19 |
| Army-SPRING Army-Suicide Prevention Research (NCT06547008) | University of Pennsylvania | 2025-03-19 |
| Effect of Cannabis on E-Cigarette Use Behavior (NCT06609109) | Johns Hopkins University | 2025-03-19 |
| Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients. (NCT06895499) | Shanghai Huaota Biopharmaceutical Co., Ltd. | 2025-03-19 |
| Impact of OnabotulinumtoxinA (BOTOX®) on Stress (NCT06778421) | Center for Advanced Facial Plastic Surgery | 2025-03-19 |
| A Single-Arm, Open-Label, Phase I Study of GK01 for Advanced Solid Tumor (NCT06954558) | Tianjin Medical University Cancer Institute and Hospital | 2025-03-18 |
| Effect of Cyclosporine Drug Interaction on the Absorption, Metabolism and Elimination of CHF6001 in Healthy Volunteers. Drug-Drug Interaction 2 (DDI2) Study (NCT06892756) | Chiesi Farmaceutici S.p.A. | 2025-03-18 |
| Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia (NCT06376162) | PedAL BCU, LLC | 2025-03-18 |
| Elotuzumab, Daratumumab, Iberdomide, and Dexamethasone for the Treatment of Relapsed Multiple Myeloma (NCT06785415) | Mayo Clinic | 2025-03-18 |
| A Study of HDM1002 in Subjects With And Without Varying Degrees Of Hepatic Impairement (NCT06985615) | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2025-03-18 |
| Intrathecal PD-1/VEGF Bispecific Antibody Plus Pemetrexed for Leptomeningeal Metastasis (NCT06809517) | Guangzhou Medical University | 2025-03-18 |
| A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian Cancer (NCT06840002) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2025-03-18 |
| Loncastuximab Tesirine and Rituximab Following Stereotactic Radiosurgery in Patients With Central Nervous System Lymphomas (SOLAR) (NCT06607549) | University of Utah | 2025-03-18 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-1301 in Healthy Subjects (NCT06857253) | Shandong Suncadia Medicine Co., Ltd. | 2025-03-18 |
| Safety and Pharmacokinetics of Extrato de Cannabis Sativa GreenCare (NCT06807762) | GreenCare Pharma | 2025-03-18 |
| A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors (NCT06803680) | BeOne Medicines | 2025-03-18 |